CompletedNot Applicable

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

Japan300 participantsStarted 2021-01-21

Plain-language summary

After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.

Who can participate

Age range19 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * outpatients belonging to American Society of Anesthesiologists class I or II * patients have erosive esophagitis diagnosed by esophagogastroduodenoscopy shortly before the prescription Exclusion Criteria: * other acid blockers are taken

What they're measuring

The number of patients who revisit our outpatient clinic after the prescription without any appointments

Timeframe: 3 months

Trial details

NCT IDNCT04720781

SponsorShowa Inan General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Gastroesophageal Reflux trials